Cell News and Research

RSS

New drug delivery system using NDs allows for direct application of chemotherapy to brain tumors

Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed a new drug delivery system using nanodiamonds (NDs) that allows for direct application of chemotherapy to brain tumors with fewer harmful side effects and better cancer-killing efficiency than existing treatments.

10 Sep 2013

Researchers identify genetic link specific to risk of childhood leukemia

For the first time, a genetic link specific to risk of childhood leukemia has been identified, according to a team of researchers from Memorial Sloan-Kettering Cancer Center, St. Jude Children's Research Hospital, University of Washington, and other institutions. The discovery was reported online today in the journal Nature Genetics.

10 Sep 2013

Ferritin protects kidneys against damage by controlling iron

A protein, ferritin, protects kidneys against a damaging after-effect of injury, heart failure or hardened arteries by controlling levels of iron, according to a study published today by researchers at the University of Alabama at Birmingham in the Journal of Clinical Investigation.

10 Sep 2013

Combined transplantation provides potential new therapy for repair of spinal cord injury

Following spinal cord injury, astrocyte proliferation and scar formation are the main factors inhibiting the regeneration and growth of spinal cord axons, leading to motor and sensory function loss below the level of spinal cord injury.

10 Sep 2013

UCSF scientists identify new way to manipulate immune system from autoimmune diseases

Scientists from UC San Francisco have identified a new way to manipulate the immune system that may keep it from attacking the body-s own molecules in autoimmune diseases such as type 1 diabetes, rheumatoid arthritis and multiple sclerosis.

10 Sep 2013

Nuclea Biotechnologies Acquires Wilex' U.S. Subsidiary

...

9 Sep 2013

Pemetrexed-erlotinib shows second-line efficacy in advanced NSCLC

Combination therapy with pemetrexed and erlotinib significantly improves progression-free survival as compared with either drug alone in patients with advanced non-squamous non-small-cell lung cancer, a phase II study has found.

9 Sep 2013

Researchers investigate importance of STAT1 phosphorylation in NK cells

Since its discovery in the early 1990s, the protein STAT1 (Signal Transducer and Activator of Transcription 1) has been found to be central in passing signals across immune cells, ensuring that our bodies react quickly and appropriately to threats from viruses or other pathogens.

7 Sep 2013

Shuyusan-containing serum protects SH-SY5Y cells against corticosterone-induced impairment

Synthetic antidepressants present a narrow spectrum and side effects following long-term application. Recently, medical practitioners have shown interest in the use of Chinese medicines for the treatment of diseases and in the adjustment of the human response to stress.

7 Sep 2013

Study reveals hydrolyzed collagen may be suitable for nerve cell culture media

In the central nervous system, nerve cells adhere to the extracellular matrix. Type I collagen is the major class of insoluble fibrous proteins in the extracellular matrix. A previous study has shown that neural stem and progenitor cells, cultured on collagen matrices, are able to expand actively and generate neurons.

7 Sep 2013

Research team receives nearly $17M to focus on nanopore technology in DNA sequencing

The use of nanopore technology aimed at more accurate and efficient DNA sequencing is the main focus of grants awarded by the National Institutes of Health. The grants - nearly $17 million to eight research teams - are the latest awarded through the National Human Genome Research Institute (NHGRI)'s Advanced DNA Sequencing Technology program, which was launched in 2004. NHGRI is part of NIH.

7 Sep 2013

FDA approves use of abraxane to treat patients with late-stage pancreatic cancer

The U.S. Food and Drug Administration today expanded the approved uses of Abraxane (paclitaxel protein-bound particles for injectable suspension, ablumin-bound) to treat patients with late-stage (metastatic) pancreatic cancer.

7 Sep 2013

Kyocera Kona offers flip phone with verbal translation enabling internet browsing for visually impaired

For the visually impaired, using a mobile device hasn't always been easy. Kyocera Kona from Sprint (NYSE: S) helps to solve that problem by providing an easy-to-use compact flip phone that is the first feature phone in the industry to offer verbal translation enabling Internet browsing.

7 Sep 2013

Researchers start Phase I clinical trial of implantable vaccine for treatment of melanoma

A cross-disciplinary team of scientists, engineers, and clinicians announced today that they have begun a Phase I clinical trial of an implantable vaccine to treat melanoma, the most lethal form of skin cancer.

7 Sep 2013

Researchers find key mechanism behind Alzheimer's disease

Alzheimer's disease affects more than 26 million people worldwide. It is predicted to skyrocket as boomers age-nearly 106 million people are projected to have the disease by 2050.

7 Sep 2013

Clinical trial of Grafix for treatment of chronic diabetic foot ulcers accepted for presentation at SAWC

Osiris Therapeutics, Inc. (NASDAQ: OSIR), announced today that its multi-center, randomized, controlled clinical trial evaluating the safety and effectiveness of Grafix® for the treatment of chronic diabetic foot ulcers has been accepted for podium presentation at the upcoming Symposium on Advanced Wound Care (SAWC) in Las Vegas on Friday, September 27, 2013.

7 Sep 2013

Cell News and Research

New drug delivery system using NDs allows for direct application of chemotherapy to brain tumors

Researchers identify genetic link specific to risk of childhood leukemia

Ferritin protects kidneys against damage by controlling iron

Combined transplantation provides potential new therapy for repair of spinal cord injury

UCSF scientists identify new way to manipulate immune system from autoimmune diseases

Nuclea Biotechnologies Acquires Wilex' U.S. Subsidiary

Pemetrexed-erlotinib shows second-line efficacy in advanced NSCLC

Researchers investigate importance of STAT1 phosphorylation in NK cells

Shuyusan-containing serum protects SH-SY5Y cells against corticosterone-induced impairment

Study reveals hydrolyzed collagen may be suitable for nerve cell culture media

Research team receives nearly $17M to focus on nanopore technology in DNA sequencing

FDA approves use of abraxane to treat patients with late-stage pancreatic cancer

Kyocera Kona offers flip phone with verbal translation enabling internet browsing for visually impaired

Researchers start Phase I clinical trial of implantable vaccine for treatment of melanoma

Researchers find key mechanism behind Alzheimer's disease

Clinical trial of Grafix for treatment of chronic diabetic foot ulcers accepted for presentation at SAWC

Endocyte, Nihon Medi-Physics Collaborate On Companion Imaging Diagnostic

New Sponge-Based Therapeutic Cancer Vaccine Begins Human Clinicals

New Type 1 Diabetes competitive landscape map released by TechAtlas Group

Endocyte, Nihon Medi-Physics Collaborate On Companion Imaging Diagnostic

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News